Walgreens Boots Alliance, Inc. with ticker code (WBA) now have 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $37.00 and $19.00 with the average share target price sitting at $23.90. (at the time of writing). Given that the stocks previous close was at $19.54 and the analysts are correct then there would likely be a percentage uptick in value of 22.3%. The 50 day MA is $21.57 while the 200 day moving average is $23.78. The market capitalization for the company is 16.14B. The current share price for the company is: $18.72 USD
The potential market cap would be $19,745,850,322 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 28.36, revenue per share of $165.00 and a 1.32% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
